Pharmaforte

MITSUBISHI TANABE PHARMA CORP

Featured products of Mitsubishi Tanabe Pharma
diltiazem hydrochloride
Packing/Price
10 × 10's
MIMS Class
Anti-Anginal Drugs, Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
diltiazem hydrochloride
Packing/Price
10 × 10's
MIMS Class
Anti-Anginal Drugs, Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
diltiazem hydrochloride
Packing/Price
10 × 10's
MIMS Class
Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
diltiazem hydrochloride
Packing/Price
3 × 10's, 10 × 10's
MIMS Class
Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
diltiazem hydrochloride
Packing/Price
3 × 10's, 10 × 10's
MIMS Class
Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
imidapril hydrochloride
Packing/Price
3 × 10's, 10 × 10's
MIMS Class
ACE Inhibitors/Direct Renin Inhibitors
ATC Classification
C09AA16 - imidapril : Belongs to the class of ACE inhibitors. Used in the treatment of cardiovascular disease.
imidapril hydrochloride
Packing/Price
10 × 10's, 3 × 10's
MIMS Class
ACE Inhibitors/Direct Renin Inhibitors
ATC Classification
C09AA16 - imidapril : Belongs to the class of ACE inhibitors. Used in the treatment of cardiovascular disease.
Distributed by Pharmaforte
diltiazem hydrochloride
Packing/Price
10 × 10's
MIMS Class
Anti-Anginal Drugs, Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
diltiazem hydrochloride
Packing/Price
10 × 10's
MIMS Class
Anti-Anginal Drugs, Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
diltiazem hydrochloride
Packing/Price
10 × 10's
MIMS Class
Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
diltiazem hydrochloride
Packing/Price
10 × 10's, 3 × 10's
MIMS Class
Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
diltiazem hydrochloride
Packing/Price
10 × 10's, 3 × 10's
MIMS Class
Calcium Antagonists
ATC Classification
C08DB01 - diltiazem : Belongs to the class of benzothiazepine derivative selective calcium-channel blockers with direct cardiac effects. Used in the treatment of cardiovascular diseases.
imidapril hydrochloride
Packing/Price
10 × 10's, 3 × 10's
MIMS Class
ACE Inhibitors/Direct Renin Inhibitors
ATC Classification
C09AA16 - imidapril : Belongs to the class of ACE inhibitors. Used in the treatment of cardiovascular disease.
imidapril hydrochloride
Packing/Price
10 × 10's, 3 × 10's
MIMS Class
ACE Inhibitors/Direct Renin Inhibitors
ATC Classification
C09AA16 - imidapril : Belongs to the class of ACE inhibitors. Used in the treatment of cardiovascular disease.

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in